Phage Display Screening Identifies a Prostate Specific Antigen (PSA)–/Lo Prostate Cancer Cell Specific Peptide to Retard Castration Resistance of Prostate Cancer

0
34
Prostate-specific antigen (PSA)+ and PSA−/lo cells were successfully separated from LNCaP xenograft tumors after prostate- PSAP-GFP vector infection and FACS.
[Translational Oncology]
Sui, Y., Zhu, R., Hu, W., Zhang, W., Zhu, H., Gong, M., Gao, L., Cao, T., Tang, T., Yu, B., & Yang, T. (2021). Phage display screening identifies a prostate specific antigen (PSA)–/lo prostate cancer cell specific peptide to retard castration resistance of prostate cancer. Translational Oncology, 14(3), 101020. https://doi.org/10.1016/j.tranon.2021.101020 Cite
Full Article